data_1fwo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fwo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 23' ' ' ARG . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.541 ' OG ' ' CZ2' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.541 ' CZ2' ' OG ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 11' ' ' PRO . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.468 ' OD1' ' OD1' ' A' ' 5' ' ' ASP . 1.3 p-10 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.571 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.535 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.571 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' OG ' ' A' ' 14' ' ' SER . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 28' ' ' VAL . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.539 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 93.5 m-70 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.563 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 7.7 p30 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' SER . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.621 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 20' ' ' PHE . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.519 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.568 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.568 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 35' ' ' GLU . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.603 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.603 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.487 ' C ' ' O ' ' A' ' 33' ' ' PRO . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.46 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.459 HG21 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.574 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.439 ' CG1' ' O ' ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.49 ' N ' ' O ' ' A' ' 32' ' ' SER . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' CE1' HG13 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.501 ' CD2' ' HB2' ' A' ' 23' ' ' ARG . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.492 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.544 ' CD2' ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.439 ' CG ' ' O ' ' A' ' 7' ' ' ASN . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 13' ' ' GLY . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 32' ' ' SER . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.594 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.482 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.488 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.594 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.46 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.506 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.504 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.541 ' OG ' ' CZ2' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.535 ' O ' ' CG1' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.541 ' CZ2' ' OG ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.504 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' A' ' 11' ' ' PRO . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.431 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 8' ' ' PHE . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' OD1' ' OD1' ' A' ' 5' ' ' ASP . 1.3 p-10 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.571 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 4' ' ' CYS . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.535 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.535 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.571 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HA ' ' OG ' ' A' ' 14' ' ' SER . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.473 ' C ' ' O ' ' A' ' 28' ' ' VAL . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.532 HD22 ' N ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.539 ' CG1' ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.539 ' N ' ' CG1' ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 93.5 m-70 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.563 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.518 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 7.7 p30 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 32' ' ' SER . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.621 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 20' ' ' PHE . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HB3' HD21 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.495 HD21 ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 ' O ' ' CG ' ' A' ' 20' ' ' PHE . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 ' N ' ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.672 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.519 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.519 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.501 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.485 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.556 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.604 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.433 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 20' ' ' PHE . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.604 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.568 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.568 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 35' ' ' GLU . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.4 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.471 ' O ' ' SG ' ' A' ' 16' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.485 ' N ' ' O ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 33' ' ' PRO . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.603 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' A' ' 20' ' ' PHE . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.603 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.487 ' C ' ' O ' ' A' ' 33' ' ' PRO . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.46 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.459 HG21 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.603 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.574 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.484 ' N ' ' O ' ' A' ' 19' ' ' ALA . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' VAL . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.646 ' CD1' HG12 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 15' ' ' THR . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' HG22 ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.524 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.804 ' O ' HG12 ' A' ' 34' ' ' VAL . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.562 ' CD1' ' HA ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 13' ' ' GLY . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.617 ' OD1' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.617 ' ND2' ' OD1' ' A' ' 5' ' ' ASP . 12.3 p30 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.531 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.474 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 18' ' ' SER . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 40.2 m80 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.429 ' ND2' ' CD2' ' A' ' 8' ' ' PHE . 1.5 p-10 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' HIS . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 15' ' ' THR . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.637 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 29' ' ' TRP . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.83 HD12 ' HE1' ' A' ' 29' ' ' TRP . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.83 ' HE1' HD12 ' A' ' 27' ' ' LEU . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.841 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.647 ' OD2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 7.4 m-20 -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.71 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 13' ' ' GLY . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.59 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 4' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.587 ' H ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.586 HG22 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' VAL . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.646 ' CD1' HG12 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 15' ' ' THR . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' HG22 ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.524 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.804 ' O ' HG12 ' A' ' 34' ' ' VAL . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.562 ' CD1' ' HA ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 13' ' ' GLY . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.617 ' OD1' ' ND2' ' A' ' 7' ' ' ASN . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.617 ' ND2' ' OD1' ' A' ' 5' ' ' ASP . 12.3 p30 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.531 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.474 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 18' ' ' SER . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 40.2 m80 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.429 ' ND2' ' CD2' ' A' ' 8' ' ' PHE . 1.5 p-10 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.429 ' CD2' ' ND2' ' A' ' 7' ' ' ASN . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' HIS . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 15' ' ' THR . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.637 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 29' ' ' TRP . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.83 HD12 ' HE1' ' A' ' 29' ' ' TRP . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.83 ' HE1' HD12 ' A' ' 27' ' ' LEU . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.841 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.647 ' OD2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 7.4 m-20 -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.71 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 13' ' ' GLY . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.59 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 4' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.587 ' H ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.586 HG22 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' VAL . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.646 ' CD1' HG12 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 15' ' ' THR . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' HG22 ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.524 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.804 ' O ' HG12 ' A' ' 34' ' ' VAL . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.562 ' CD1' ' HA ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 13' ' ' GLY . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.468 ' OD1' ' OD1' ' A' ' 5' ' ' ASP . 1.3 p-10 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.464 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.531 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.474 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 18' ' ' SER . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 93.5 m-70 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 7.7 p30 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' HIS . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 15' ' ' THR . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.637 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 29' ' ' TRP . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.83 HD12 ' HE1' ' A' ' 29' ' ' TRP . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.83 ' HE1' HD12 ' A' ' 27' ' ' LEU . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.841 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.647 ' OD2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.71 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 13' ' ' GLY . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.59 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.475 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 4' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.587 ' H ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.586 HG22 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.302 0.572 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -101.46 -171.08 1.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.321 -0.862 . . . . 0.0 109.966 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.686 ' O ' HG13 ' A' ' 3' ' ' VAL . 7.1 p -169.49 95.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 0.0 110.46 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 6' ' ' ASP . 7.7 m -87.21 142.19 28.09 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 0.0 110.15 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.426 ' OD1' ' C ' ' A' ' 5' ' ' ASP . 41.8 t0 54.39 -92.34 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.282 -0.886 . . . . 0.0 110.221 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 4' ' ' CYS . 1.1 m-20 -151.41 -86.11 0.07 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.198 -0.938 . . . . 0.0 110.136 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.17 76.8 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.082 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 9' ' ' SER . 29.6 t80 -170.68 156.41 5.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 109.985 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.491 ' N ' ' CD1' ' A' ' 8' ' ' PHE . 24.2 p -172.6 149.41 2.08 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.107 -0.996 . . . . 0.0 110.654 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -158.83 125.79 2.59 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.434 -0.791 . . . . 0.0 109.666 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.95 58.97 2.18 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.878 1.462 . . . . 0.0 110.552 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 45.48 23.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 110.311 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.13 12.6 44.67 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.49 ' CA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m -168.91 -164.43 0.48 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.378 -1.072 . . . . 0.0 109.839 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 1.1 p -138.7 155.12 48.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.124 -0.985 . . . . 0.0 110.295 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 76.3 m -79.68 101.27 8.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.255 -0.903 . . . . 0.0 110.452 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 72.2 m -45.99 -43.53 14.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 2.4 t 61.63 115.79 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.491 -0.755 . . . . 0.0 110.658 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 28' ' ' VAL . . . -136.84 -176.4 4.35 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.406 -0.809 . . . . 0.0 109.644 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.646 ' CD1' HG12 ' A' ' 28' ' ' VAL . 1.1 m-85 54.49 63.41 2.17 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.0 110.031 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.5 18.47 20.29 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.76 ' CZ ' HD21 ' A' ' 25' ' ' LEU . 26.1 p90 -101.08 8.52 42.82 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.207 -1.172 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.51 ' HB2' ' CD2' ' A' ' 22' ' ' PHE . 0.6 OUTLIER 170.21 -25.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.277 -0.889 . . . . 0.0 109.974 -179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ARG . 4.3 m120 60.59 81.45 0.18 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.478 -0.764 . . . . 0.0 110.945 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -121.18 12.64 11.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.355 -0.841 . . . . 0.0 109.447 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -177.29 -32.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.471 -0.768 . . . . 0.0 109.874 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.569 HD22 ' N ' ' A' ' 27' ' ' LEU . 4.4 mm? 56.97 111.74 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.385 -0.822 . . . . 0.0 110.493 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.706 HG13 ' O ' ' A' ' 28' ' ' VAL . 12.9 p -145.79 108.98 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.366 -0.834 . . . . 0.0 110.285 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.564 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER -153.82 -161.41 1.25 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.259 -0.901 . . . . 0.0 109.822 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.66 -171.6 23.02 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.596 -1.288 . . . . 0.0 110.075 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -99.14 143.31 29.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.412 -1.052 . . . . 0.0 110.157 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.49 ' O ' ' CA ' ' A' ' 14' ' ' SER . 0.2 OUTLIER -111.95 139.04 21.9 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.139 -0.976 . . . . 0.0 110.084 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.71 119.41 5.9 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.97 1.51 . . . . 0.0 110.609 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -63.91 -24.45 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.291 -0.881 . . . . 0.0 110.376 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.174 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.235 0.54 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.48 ' O ' ' O ' ' A' ' 3' ' ' VAL . 2.2 m-70 -121.61 -8.25 9.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.352 -0.842 . . . . 0.0 110.186 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 13.1 t 57.39 116.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.363 -0.836 . . . . 0.0 110.067 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' PHE . 1.2 m -113.08 102.07 10.05 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 110.471 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.1 t70 45.6 48.78 11.22 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.449 -0.782 . . . . 0.0 110.563 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 8' ' ' PHE . 0.3 OUTLIER 52.56 -179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.935 . . . . 0.0 110.251 179.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.439 ' O ' ' CG ' ' A' ' 8' ' ' PHE . 33.1 t30 42.34 26.96 0.07 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.354 -0.841 . . . . 0.0 110.05 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -171.82 159.21 5.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.242 -0.912 . . . . 0.0 110.243 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 62.8 p -134.23 -85.29 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.316 -0.865 . . . . 0.0 109.78 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' O ' ' O ' ' A' ' 9' ' ' SER . 86.7 m 56.92 118.01 0.01 OUTLIER Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.614 -0.679 . . . . 0.0 110.394 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.69 -160.45 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.783 1.412 . . . . 0.0 110.097 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.91 -24.68 64.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.052 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 34' ' ' VAL . . . -68.77 -70.13 1.23 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 32' ' ' SER . 0.4 OUTLIER -40.33 161.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.264 -1.139 . . . . 0.0 110.468 -179.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 15' ' ' THR . 15.2 t -124.97 126.15 45.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.2 -0.938 . . . . 0.0 110.686 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.8 m -98.06 108.92 21.73 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.183 -0.948 . . . . 0.0 109.521 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.462 ' O ' ' OG ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -96.46 -31.4 12.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.86 . . . . 0.0 111.15 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.614 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 1.1 p 66.54 121.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.097 -1.002 . . . . 0.0 109.613 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.464 ' O ' ' O ' ' A' ' 27' ' ' LEU . . . -154.98 -157.81 0.79 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.037 -1.039 . . . . 0.0 110.921 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LEU . 86.3 m-85 -134.82 -116.49 0.19 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.417 -0.802 . . . . 0.0 110.222 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.22 -120.79 0.68 Allowed Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 34.5 p90 -94.46 6.33 49.09 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -1.16 . . . . 0.0 110.456 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -167.0 -53.55 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' LEU . 1.9 p30 -173.77 -68.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.035 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' O ' ' CB ' ' A' ' 26' ' ' SER . 3.5 mm? 41.82 36.82 0.67 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.0 110.179 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 1.6 m 66.22 167.47 0.21 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.234 -0.916 . . . . 0.0 109.914 -179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' VAL . 2.1 mt -44.61 -91.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -0.903 . . . . 0.0 110.12 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 19.6 t 61.28 109.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.203 -0.936 . . . . 0.0 110.866 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.614 ' CG ' ' HA ' ' A' ' 18' ' ' SER . 0.0 OUTLIER -148.76 -164.03 1.93 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.263 -0.898 . . . . 0.0 109.989 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.48 -138.62 4.35 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.805 -1.188 . . . . 0.0 110.161 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.6 t -170.06 140.0 1.92 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.251 -1.146 . . . . 0.0 109.926 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' HG22 ' A' ' 15' ' ' THR . 16.4 m -139.92 155.19 71.1 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.13 -0.981 . . . . 0.0 110.587 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.7 Cg_endo -75.5 72.4 4.97 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 124.117 1.588 . . . . 0.0 110.424 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 13' ' ' GLY . 5.0 t 40.72 49.39 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.339 -0.851 . . . . 0.0 110.642 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.235 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.6 t0 . . . . . 0 N--CA 1.495 1.787 0 CA-C-O 121.214 0.53 . . . . 0.0 110.125 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.3 OUTLIER -83.93 155.07 23.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 0.0 110.394 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -114.85 106.91 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.295 -0.878 . . . . 0.0 109.407 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.6 OUTLIER -74.59 108.58 7.45 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 110.961 -179.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.524 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 4.4 m-20 35.95 46.68 0.37 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.635 -0.666 . . . . 0.0 111.129 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.492 ' O ' ' N ' ' A' ' 8' ' ' PHE . 2.3 t70 53.95 -179.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.108 -0.995 . . . . 0.0 110.18 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' CB ' ' O ' ' A' ' 6' ' ' ASP . 29.4 t30 66.87 -60.36 0.35 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.0 110.181 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 31' ' ' CYS . 4.6 t80 -110.93 162.19 15.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.78 145.65 36.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.16 -0.962 . . . . 0.0 110.094 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 2' ' ' HIS . 51.8 m -137.51 155.66 75.29 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 110.127 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -88.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 124.05 1.553 . . . . 0.0 110.603 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -158.35 -39.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.17 -0.956 . . . . 0.0 110.095 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.804 ' O ' HG12 ' A' ' 34' ' ' VAL . . . -70.14 -6.57 57.48 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.9 m -113.53 166.04 11.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.12 -1.223 . . . . 0.0 110.426 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.2 m -155.36 147.98 24.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 17.8 p -113.42 170.04 8.52 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.193 -0.942 . . . . 0.0 110.159 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 18' ' ' SER . 2.4 t -117.46 -26.56 6.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.285 -0.884 . . . . 0.0 110.624 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.562 ' HA ' ' CD1' ' A' ' 29' ' ' TRP . 1.1 m 58.05 113.67 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.244 -0.91 . . . . 0.0 109.988 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' C ' ' CG ' ' A' ' 20' ' ' PHE . . . -154.96 -173.97 4.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.033 -1.042 . . . . 0.0 110.708 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.545 ' CG ' ' C ' ' A' ' 19' ' ' ALA . 3.1 m-85 -150.96 -62.35 0.19 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.405 -0.809 . . . . 0.0 109.963 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 140.13 -160.84 26.37 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -60.88 -17.75 52.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -1.151 . . . . 0.0 110.212 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.47 ' O ' ' CB ' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -83.08 -44.14 15.48 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.261 -0.899 . . . . 0.0 110.149 179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 1.2 t30 67.32 40.67 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.268 -0.895 . . . . 0.0 110.519 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.64 HD12 ' C ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -154.95 18.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.148 -0.97 . . . . 0.0 110.329 179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.471 ' N ' HD12 ' A' ' 25' ' ' LEU . 1.9 p -139.85 93.44 2.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.903 . . . . 0.0 110.092 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -50.67 120.96 5.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 110.227 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.793 HG13 ' O ' ' A' ' 28' ' ' VAL . 10.0 p -136.77 72.5 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.224 -0.923 . . . . 0.0 110.49 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.562 ' CD1' ' HA ' ' A' ' 18' ' ' SER . 59.1 p-90 -163.67 -160.87 0.61 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.1 -1.0 . . . . 0.0 110.453 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.433 ' O ' ' CE3' ' A' ' 29' ' ' TRP . . . -169.55 -104.16 0.17 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 4.1 t -150.66 167.53 27.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -1.129 . . . . 0.0 110.117 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.46 149.73 14.01 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.282 -0.886 . . . . 0.0 110.092 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.34 151.94 43.66 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.006 1.529 . . . . 0.0 110.415 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.804 HG12 ' O ' ' A' ' 13' ' ' GLY . 13.2 p -103.82 50.56 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 29.9 tt0 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.17 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t0 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.264 0.554 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -100.41 -172.82 2.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 110.107 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 3' ' ' VAL . 5.2 p -148.07 129.3 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.156 -0.965 . . . . 0.0 110.57 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 31' ' ' CYS . 5.7 m -129.68 128.83 43.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.3 -0.875 . . . . 0.0 109.556 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.479 ' OD1' ' HB2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER 63.87 11.44 5.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.644 -179.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER 68.59 -83.89 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 110.75 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.468 ' OD1' ' OD1' ' A' ' 5' ' ' ASP . 1.3 p-10 -50.14 -28.45 7.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 0.0 110.341 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.591 ' CD2' ' HA3' ' A' ' 30' ' ' GLY . 3.8 t80 -103.16 149.38 24.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.169 -0.957 . . . . 0.0 109.673 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 78.5 p -150.78 165.61 32.99 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.076 . . . . 0.0 110.695 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -144.88 136.97 13.12 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.838 . . . . 0.0 109.858 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' O ' ' N ' ' A' ' 13' ' ' GLY . 46.8 Cg_endo -73.89 72.12 3.98 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.889 1.468 . . . . 0.0 111.215 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 11' ' ' PRO . . . 40.82 26.39 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.261 -0.899 . . . . 0.0 110.814 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 11' ' ' PRO . . . -131.08 45.89 1.11 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.519 ' CB ' ' SG ' ' A' ' 10' ' ' CYS . 0.6 OUTLIER -174.06 -158.05 0.08 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.324 -1.104 . . . . 0.0 110.197 -179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -148.77 121.15 8.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.214 -0.929 . . . . 0.0 110.271 -179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 m -67.2 102.26 1.02 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.216 -0.928 . . . . 0.0 109.766 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.512 ' O ' ' CE3' ' A' ' 29' ' ' TRP . 0.0 OUTLIER -108.06 131.55 54.48 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.193 -0.942 . . . . 0.0 110.71 -179.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 29' ' ' TRP . 22.3 m -87.73 127.17 35.31 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -0.879 . . . . 0.0 110.176 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' ' HB3' ' A' ' 29' ' ' TRP . . . -178.19 167.77 1.95 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.342 -0.849 . . . . 0.0 110.246 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.635 ' CD1' ' N ' ' A' ' 20' ' ' PHE . 0.0 OUTLIER -123.5 -80.96 0.63 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.989 . . . . 0.0 110.398 179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.47 -69.65 0.02 OUTLIER Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.067 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 15.6 p90 -158.38 -35.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -1.151 . . . . 0.0 110.907 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 24' ' ' ASN . 20.6 ttt180 -100.73 -87.53 0.38 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.937 -179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.464 ' N ' ' HG2' ' A' ' 23' ' ' ARG . 56.3 t-20 -160.27 62.23 0.33 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 110.714 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -91.42 42.6 1.11 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.191 -0.943 . . . . 0.0 109.824 179.663 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.589 ' O ' ' CD1' ' A' ' 20' ' ' PHE . 1.4 t 70.21 -160.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.189 -0.945 . . . . 0.0 109.455 -179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . 3.2 mp -73.16 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.911 -1.118 . . . . 0.0 110.054 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 27' ' ' LEU . 3.5 t 64.81 75.95 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 110.548 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.531 ' CD2' ' HA ' ' A' ' 18' ' ' SER . 26.3 p-90 -151.55 -176.52 5.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.097 -1.002 . . . . 0.0 110.416 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 8' ' ' PHE . . . -156.3 -120.72 0.68 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 15' ' ' THR . 6.7 p -147.67 133.64 19.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.223 -1.163 . . . . 0.0 110.473 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -94.93 152.04 39.34 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.303 -0.873 . . . . 0.0 110.233 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.14 128.19 13.6 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.917 1.483 . . . . 0.0 110.391 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 34' ' ' VAL . 8.7 p -90.57 36.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 110.246 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.273 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.22 0.533 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -123.56 152.98 41.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.244 -0.91 . . . . 0.0 110.175 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 3' ' ' VAL . 15.9 m -124.84 127.55 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.872 . . . . 0.0 110.371 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.474 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 61.4 m -89.19 -37.54 14.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.346 -0.846 . . . . 0.0 109.938 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 8' ' ' PHE . 14.2 t70 -156.22 147.95 22.89 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -0.868 . . . . 0.0 110.058 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 5' ' ' ASP . 48.4 m-20 -42.4 -30.34 0.33 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.302 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -101.84 28.41 5.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.95 . . . . 0.0 110.204 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 5' ' ' ASP . 0.3 OUTLIER -159.99 173.61 15.61 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.366 -0.834 . . . . 0.0 109.906 179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 22.8 p -167.7 -170.07 1.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.11 -0.994 . . . . 0.0 110.326 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.1 OUTLIER 173.12 148.79 0.21 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.283 -0.885 . . . . 0.0 110.444 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.61 -159.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.109 1.584 . . . . 0.0 110.265 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.11 -10.91 34.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.205 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.35 -27.68 51.12 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 33' ' ' PRO . 0.4 OUTLIER -102.64 -179.93 4.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -1.209 . . . . 0.0 110.253 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.06 165.4 27.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.7 m -88.86 113.25 24.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -0.884 . . . . 0.0 110.322 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 18' ' ' SER . 47.2 t -65.32 -106.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.165 -0.959 . . . . 0.0 109.945 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.639 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 168.13 110.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.858 -1.151 . . . . 0.0 110.773 179.653 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 18' ' ' SER . . . 65.9 179.43 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.426 -0.796 . . . . 0.0 110.836 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 25' ' ' LEU . 10.3 m-85 -47.15 177.3 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.545 -0.722 . . . . 0.0 110.681 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -98.21 -2.94 57.88 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -138.57 -97.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -1.232 . . . . 0.0 109.989 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -71.66 -151.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.992 -1.068 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.423 ' O ' ' C ' ' A' ' 25' ' ' LEU . 5.5 p30 -123.6 44.88 2.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.214 -0.929 . . . . 0.0 109.888 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.592 ' HB2' ' CE1' ' A' ' 20' ' ' PHE . 0.5 OUTLIER -41.34 -31.33 0.23 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.453 -0.779 . . . . 0.0 110.538 -179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 178.67 -78.69 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.119 -0.988 . . . . 0.0 110.115 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -175.01 24.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.957 -1.089 . . . . 0.0 111.244 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.547 HG12 ' N ' ' A' ' 29' ' ' TRP . 6.6 t -47.51 174.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.947 -1.096 . . . . 0.0 109.261 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.547 ' N ' HG12 ' A' ' 28' ' ' VAL . 58.5 m95 -131.4 135.79 47.48 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.666 -1.271 . . . . 0.0 110.677 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -110.37 81.25 0.28 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.1 149.06 7.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.167 -1.196 . . . . 0.0 110.072 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.1 m -144.77 138.5 14.47 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.329 -0.857 . . . . 0.0 110.378 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 47.8 Cg_endo -72.4 119.63 6.25 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.0 1.526 . . . . 0.0 110.576 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.3 t -71.59 69.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 109.93 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.271 -179.815 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.25 0.548 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.454 ' O ' ' O ' ' A' ' 9' ' ' SER . 93.5 m-70 -107.89 80.55 1.39 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.317 -0.864 . . . . 0.0 110.112 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 4.0 m -70.66 150.13 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.137 -0.977 . . . . 0.0 110.6 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.571 ' HB3' ' CZ3' ' A' ' 29' ' ' TRP . 82.1 m -103.69 -70.82 0.75 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 38.7 t70 -122.66 41.97 3.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.363 -0.836 . . . . 0.0 110.103 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 73.89 -4.06 2.36 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.494 -0.753 . . . . 0.0 111.049 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 5' ' ' ASP . 7.7 p30 -123.85 15.1 9.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.016 -1.053 . . . . 0.0 110.103 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -140.6 -176.45 4.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.332 -0.855 . . . . 0.0 109.881 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' HIS . 2.8 t -164.71 -43.0 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.114 -0.991 . . . . 0.0 110.816 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.434 ' C ' ' O ' ' A' ' 9' ' ' SER . 2.7 m 43.48 86.79 0.13 Allowed Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.282 -0.886 . . . . 0.0 108.943 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.87 -50.43 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.018 1.536 . . . . 0.0 111.233 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -55.01 -27.15 42.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.951 -1.093 . . . . 0.0 109.867 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.459 ' O ' ' C ' ' A' ' 14' ' ' SER . . . 127.37 -55.2 0.75 Allowed Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.494 ' CA ' ' O ' ' A' ' 32' ' ' SER . 1.1 m 37.25 -145.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.684 -0.892 . . . . 0.0 110.586 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.655 ' O ' HG22 ' A' ' 15' ' ' THR . 2.3 m -172.56 87.58 0.08 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.427 -0.795 . . . . 0.0 109.695 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.459 ' O ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -43.97 167.13 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 109.841 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.5 m -158.16 20.93 0.25 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.221 -0.924 . . . . 0.0 110.548 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.637 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . 0.1 OUTLIER 47.56 87.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.188 -0.945 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 29' ' ' TRP . . . -102.56 -154.4 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.183 -0.948 . . . . 0.0 110.028 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER 67.1 124.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.937 . . . . 0.0 110.259 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 24.59 0.14 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -88.43 -62.46 1.48 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -1.116 . . . . 0.0 109.784 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.488 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -117.32 -18.08 9.98 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 109.445 179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.432 ' CB ' ' O ' ' A' ' 23' ' ' ARG . 0.1 OUTLIER 65.44 82.56 0.18 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.475 -0.766 . . . . 0.0 110.394 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -138.05 -29.09 0.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.172 -0.955 . . . . 0.0 111.008 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -139.01 0.55 1.96 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.943 -1.098 . . . . 0.0 110.922 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.83 HD12 ' HE1' ' A' ' 29' ' ' TRP . 1.1 mm? 54.59 -86.57 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.025 . . . . 0.0 110.533 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 26' ' ' SER . 97.9 t 47.5 95.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.743 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.83 ' HE1' HD12 ' A' ' 27' ' ' LEU . 1.3 m0 -85.93 -140.99 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.142 -0.974 . . . . 0.0 109.949 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -153.76 134.96 4.57 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 14' ' ' SER . 73.1 m -66.77 78.34 0.12 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.302 -1.116 . . . . 0.0 109.997 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -51.97 134.53 38.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 0.0 110.032 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.04 150.84 55.08 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.923 1.486 . . . . 0.0 110.501 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -96.83 62.19 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.256 -0.902 . . . . 0.0 110.278 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.921 -1.037 . . . . 0.0 110.11 179.901 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.506 ' CA ' ' O ' ' A' ' 10' ' ' CYS . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.337 0.589 . . . . 0.0 110.148 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.841 ' O ' HG12 ' A' ' 3' ' ' VAL . 10.7 p80 -30.42 150.49 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.43 0.633 . . . . 0.0 111.745 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.841 HG12 ' O ' ' A' ' 2' ' ' HIS . 0.3 OUTLIER 55.27 146.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-O 121.789 0.804 . . . . 0.0 111.749 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.532 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 0.5 OUTLIER 174.68 85.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.667 -0.645 . . . . 0.0 109.419 179.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.647 ' OD2' HD21 ' A' ' 27' ' ' LEU . 0.2 OUTLIER 70.5 21.72 5.43 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.325 -0.86 . . . . 0.0 109.939 -179.467 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.67 19.84 0.98 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.8 t30 -141.54 11.08 2.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.103 -0.998 . . . . 0.0 110.284 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.532 ' O ' ' CB ' ' A' ' 4' ' ' CYS . 23.0 t80 -177.71 165.31 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 110.396 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' ' 8' ' ' PHE . 1.4 p 170.75 143.35 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.375 -0.828 . . . . 0.0 110.462 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.519 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.6 OUTLIER -122.99 -172.71 0.25 Allowed Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.478 -0.764 . . . . 0.0 109.09 179.582 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HD2' ' HB3' ' A' ' 10' ' ' CYS . 46.8 Cg_endo -88.8 -169.72 0.43 Allowed 'Trans proline' 0 C--N 1.302 -1.887 0 O-C-N 123.057 1.03 . . . . 0.0 110.66 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 1' ' ' ASP . . . -84.01 2.31 39.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.376 -0.827 . . . . 0.0 110.428 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.825 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -88.96 -28.73 20.11 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 31' ' ' CYS . 3.4 m -107.69 -148.07 0.42 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -1.169 . . . . 0.0 110.129 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 7.7 m -162.26 121.53 2.33 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.211 -0.931 . . . . 0.0 110.403 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.94 121.68 7.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.388 -0.82 . . . . 0.0 110.243 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 18' ' ' SER . 0.6 OUTLIER -72.13 -87.01 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.091 -1.005 . . . . 0.0 110.139 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -178.57 -134.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 110.75 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HB1' ' O ' ' A' ' 27' ' ' LEU . . . 170.04 165.09 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.147 -0.97 . . . . 0.0 109.792 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.607 ' CZ ' ' HB ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -110.79 103.82 12.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.86 -1.15 . . . . 0.0 110.85 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -88.26 3.77 85.45 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.311 -1.515 . . . . 0.0 109.311 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.499 ' O ' ' CB ' ' A' ' 23' ' ' ARG . 10.6 t80 -128.04 149.85 50.2 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.296 -1.12 . . . . 0.0 109.775 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.527 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER 69.77 -55.52 0.59 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.069 -1.019 . . . . 0.0 110.209 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.407 ' O ' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER -83.52 -11.13 57.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.194 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.77 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.1 mm? 48.7 29.58 2.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.245 -0.91 . . . . 0.0 110.233 -179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.565 ' O ' HD12 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -142.15 -157.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.285 -0.884 . . . . 0.0 109.734 179.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.71 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -128.99 -68.8 0.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.03 -1.044 . . . . 0.0 110.227 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.607 ' HB ' ' CZ ' ' A' ' 20' ' ' PHE . 17.8 t 56.97 111.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 109.96 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.556 ' CD2' ' O ' ' A' ' 18' ' ' SER . 32.9 m95 -117.7 179.53 4.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.044 -1.035 . . . . 0.0 110.622 -179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 17' ' ' SER . . . -144.34 151.97 23.92 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 14' ' ' SER . 11.8 t -122.77 117.04 24.76 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.035 -1.273 . . . . 0.0 110.002 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.96 109.62 63.33 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 110.329 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.26 156.73 50.78 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.021 1.538 . . . . 0.0 110.299 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.825 HG23 ' O ' ' A' ' 13' ' ' GLY . 59.6 t -81.01 -20.82 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.341 -0.85 . . . . 0.0 110.152 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.268 179.912 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.177 0.513 . . . . 0.0 110.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -95.62 -163.61 1.07 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.232 -0.917 . . . . 0.0 110.358 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 3' ' ' VAL . 3.1 p -159.14 118.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.187 -0.946 . . . . 0.0 110.37 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.521 ' HB3' ' CG ' ' A' ' 29' ' ' TRP . 19.5 m -105.63 99.52 9.12 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.277 -0.889 . . . . 0.0 109.996 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.59 ' HB2' ' NE1' ' A' ' 29' ' ' TRP . 23.9 t0 69.86 15.77 7.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.283 -0.885 . . . . 0.0 110.41 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.529 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 4.8 t70 72.76 -50.74 0.7 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.405 -0.809 . . . . 0.0 111.015 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.492 ' ND2' ' O ' ' A' ' 7' ' ' ASN . 4.6 p-10 -73.05 52.75 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.956 -1.09 . . . . 0.0 110.597 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.474 ' HB2' ' O ' ' A' ' 7' ' ' ASN . 1.6 t80 178.93 -171.22 0.13 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.935 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.2 p -167.62 156.07 9.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.172 -0.955 . . . . 0.0 110.264 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.36 144.92 6.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.389 -0.819 . . . . 0.0 109.788 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.09 166.27 30.12 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.892 1.47 . . . . 0.0 110.566 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.96 -16.54 64.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 110.306 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.24 -12.87 69.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' SER . 38.4 m -119.95 -149.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.335 -1.097 . . . . 0.0 110.353 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 14' ' ' SER . 9.1 m -169.53 148.64 3.79 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.284 -0.885 . . . . 0.0 110.314 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.475 ' HB3' ' CE3' ' A' ' 29' ' ' TRP . 56.1 m -69.66 99.78 1.37 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.228 -0.92 . . . . 0.0 110.131 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 30' ' ' GLY . 1.0 OUTLIER -51.43 -91.78 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.053 -1.029 . . . . 0.0 110.111 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.523 ' N ' ' OG ' ' A' ' 17' ' ' SER . 95.2 p -175.54 -89.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 112.038 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' N ' ' OG ' ' A' ' 18' ' ' SER . . . -106.75 -159.77 0.71 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.195 -0.941 . . . . 0.0 111.086 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 24' ' ' ASN . 10.9 p90 -66.14 -158.08 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.435 -0.791 . . . . 0.0 110.233 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.502 ' N ' ' CD2' ' A' ' 20' ' ' PHE . . . 150.02 38.75 0.03 OUTLIER Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.439 ' CG ' ' N ' ' A' ' 23' ' ' ARG . 13.5 p90 -150.02 -35.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.144 -1.21 . . . . 0.0 110.367 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' N ' ' CG ' ' A' ' 22' ' ' PHE . 4.8 tpp85 -177.42 -46.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.125 -0.984 . . . . 0.0 110.535 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.571 ' O ' ' CD2' ' A' ' 20' ' ' PHE . 26.4 t-20 -76.52 139.96 40.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 0.0 110.669 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.8 49.33 1.44 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.386 -0.821 . . . . 0.0 110.095 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 27' ' ' LEU . 8.8 t -116.59 -163.35 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.306 -0.871 . . . . 0.0 110.109 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.531 ' O ' ' N ' ' A' ' 20' ' ' PHE . 1.7 mm? -79.32 -84.7 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.035 -1.041 . . . . 0.0 110.29 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.557 ' C ' ' CD1' ' A' ' 29' ' ' TRP . 2.4 t 56.05 167.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 120.926 -1.109 . . . . 0.0 108.947 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.59 ' NE1' ' HB2' ' A' ' 5' ' ' ASP . 45.2 m95 -139.31 134.41 32.53 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.039 -1.038 . . . . 0.0 110.32 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.538 ' O ' ' CB ' ' A' ' 17' ' ' SER . . . -96.13 104.32 3.07 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.84 126.1 26.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.984 -1.304 . . . . 0.0 110.007 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -130.35 170.78 10.25 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.245 -0.909 . . . . 0.0 110.148 -179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.93 123.48 9.35 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.054 1.555 . . . . 0.0 110.919 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 34' ' ' VAL . 3.7 p -66.84 86.48 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.391 -0.818 . . . . 0.0 110.132 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' C ' ' O ' ' A' ' 34' ' ' VAL . 1.9 mt-10 . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.761 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.243 0.544 . . . . 0.0 110.047 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.528 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.1 OUTLIER -61.97 -157.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 0.0 110.339 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.587 HG12 ' H ' ' A' ' 4' ' ' CYS . 13.3 t -134.11 178.41 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.18 -0.95 . . . . 0.0 109.911 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.587 ' H ' HG12 ' A' ' 3' ' ' VAL . 0.1 OUTLIER -158.69 79.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.226 -0.921 . . . . 0.0 110.268 179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.474 ' O ' ' CB ' ' A' ' 6' ' ' ASP . 0.9 OUTLIER 64.84 24.27 12.75 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.394 -0.816 . . . . 0.0 111.26 179.316 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 8.3 t0 68.55 -0.06 2.41 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.018 -1.051 . . . . 0.0 111.305 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -103.41 -23.98 13.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.845 -1.16 . . . . 0.0 110.197 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.485 ' O ' ' N ' ' A' ' 4' ' ' CYS . 66.7 t80 -151.82 166.84 30.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.327 -0.858 . . . . 0.0 110.039 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 2' ' ' HIS . 0.5 OUTLIER -129.22 146.42 51.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 110.264 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' O ' ' N ' ' A' ' 2' ' ' HIS . 15.7 m -101.09 163.65 17.56 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.273 -0.892 . . . . 0.0 109.538 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -76.21 -90.16 0.0 OUTLIER 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.816 1.43 . . . . 0.0 110.529 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.07 0.58 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.235 -0.915 . . . . 0.0 110.232 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 14' ' ' SER . . . -86.62 -78.57 1.22 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.414 ' C ' ' O ' ' A' ' 13' ' ' GLY . 0.3 OUTLIER 43.74 -156.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -1.206 . . . . 0.0 110.352 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.463 ' O ' ' N ' ' A' ' 32' ' ' SER . 23.7 m -163.3 131.26 3.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.388 -0.82 . . . . 0.0 110.26 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 3' ' ' VAL . 1.5 m -82.11 124.56 29.96 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.217 -0.927 . . . . 0.0 110.092 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 18' ' ' SER . 14.6 m -94.54 -149.26 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.365 -0.834 . . . . 0.0 110.577 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.593 ' HA ' ' CE2' ' A' ' 29' ' ' TRP . 3.7 t 168.94 51.31 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.478 -0.764 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 27' ' ' LEU . . . -64.91 -164.9 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.46 -0.775 . . . . 0.0 111.411 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 27' ' ' LEU . 34.5 m-85 -153.2 -85.96 0.06 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.53 -0.731 . . . . 0.0 110.232 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.62 -72.16 0.1 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 23' ' ' ARG . 0.1 OUTLIER -140.95 -38.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.175 -1.191 . . . . 0.0 109.853 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -123.03 -85.03 0.66 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.357 -0.839 . . . . 0.0 109.929 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -175.89 54.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.203 -0.936 . . . . 0.0 110.233 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 29.5 mt -97.88 -51.48 4.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.361 -0.837 . . . . 0.0 109.966 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 20' ' ' PHE . 1.2 m -134.37 130.3 36.7 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.746 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER -53.94 -64.51 0.8 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.763 -179.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.7 t 60.87 97.66 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.17 -0.956 . . . . 0.0 110.306 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.593 ' CE2' ' HA ' ' A' ' 18' ' ' SER . 58.6 p-90 179.54 -159.85 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.307 -0.871 . . . . 0.0 110.386 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.38 178.58 46.15 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 15' ' ' THR . 0.8 OUTLIER -73.24 136.23 44.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -1.146 . . . . 0.0 110.187 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 15' ' ' THR . 1.3 p -95.69 127.95 39.62 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' O ' ' C ' ' A' ' 34' ' ' VAL . 44.5 Cg_endo -72.43 60.4 3.34 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.866 1.456 . . . . 0.0 110.872 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 34' ' ' VAL . 12.2 p 32.02 52.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.816 -0.552 . . . . 0.0 111.384 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.099 -1.001 . . . . 0.0 110.163 179.777 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.263 0.554 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.461 ' N ' ' O ' ' A' ' 10' ' ' CYS . 0.0 OUTLIER -150.59 179.6 8.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.177 -0.952 . . . . 0.0 110.332 -179.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 3.1 m -145.2 140.6 22.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.103 -0.998 . . . . 0.0 110.425 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.7 t -102.52 -46.42 4.77 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.203 -0.936 . . . . 0.0 110.796 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 60.1 m-20 -144.92 43.08 1.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.932 -1.105 . . . . 0.0 110.87 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER 66.95 -59.95 0.37 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.168 -0.957 . . . . 0.0 110.869 179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.478 ' N ' ' O ' ' A' ' 5' ' ' ASP . 39.2 t30 -60.89 -10.86 6.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.293 -0.879 . . . . 0.0 110.789 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.484 ' HB2' ' CH2' ' A' ' 29' ' ' TRP . 3.7 t80 -127.78 -173.73 3.0 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.113 -0.992 . . . . 0.0 110.187 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 3' ' ' VAL . 6.2 p -156.39 -90.91 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 110.533 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 2' ' ' HIS . 0.1 OUTLIER 63.93 157.96 0.12 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.122 -0.986 . . . . 0.0 110.237 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.67 -179.36 4.46 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.913 1.481 . . . . 0.0 110.739 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.01 -28.77 49.24 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.259 -0.901 . . . . 0.0 110.211 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -51.05 -56.78 12.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 m -86.68 179.38 6.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.323 -1.104 . . . . 0.0 110.032 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.586 HG22 ' SG ' ' A' ' 16' ' ' CYS . 49.3 m -126.29 -106.74 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.333 -0.854 . . . . 0.0 109.456 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER -167.76 126.45 1.26 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.758 -1.214 . . . . 0.0 110.515 179.171 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.1 OUTLIER -41.34 -69.53 0.13 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.625 -0.672 . . . . 0.0 109.909 179.768 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.591 ' O ' ' CD2' ' A' ' 29' ' ' TRP . 6.3 t 176.13 -111.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 111.201 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' HA ' ' CG ' ' A' ' 29' ' ' TRP . . . -166.4 -54.03 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.748 -1.22 . . . . 0.0 110.24 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.78 -162.75 1.6 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.705 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -80.17 -96.36 0.35 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.588 ' CE1' ' HD2' ' A' ' 23' ' ' ARG . 11.5 p90 -132.86 11.67 4.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -1.182 . . . . 0.0 109.931 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.588 ' HD2' ' CE1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -124.62 -122.24 0.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 0.0 109.873 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 25' ' ' LEU . 47.0 m-80 -146.61 31.22 0.98 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.862 -1.149 . . . . 0.0 110.155 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -41.95 -49.16 4.61 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.393 -0.817 . . . . 0.0 110.073 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER 169.81 167.73 0.05 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.382 -0.824 . . . . 0.0 109.745 -179.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.9 mt -78.21 79.03 4.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 110.48 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.528 ' O ' HG12 ' A' ' 28' ' ' VAL . 3.3 t -111.79 97.92 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.38 -0.825 . . . . 0.0 109.36 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 29' ' ' TRP . 2.2 p-90 -157.22 -155.37 0.52 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.233 -0.917 . . . . 0.0 110.621 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.64 -152.74 10.33 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 119.107 -1.521 . . . . 0.0 110.625 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -84.02 176.82 8.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.531 -0.981 . . . . 0.0 111.167 -179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.442 ' OG ' ' N ' ' A' ' 16' ' ' CYS . 90.6 p -169.79 143.36 2.14 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.577 -0.702 . . . . 0.0 109.766 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -71.21 126.99 12.89 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.805 1.424 . . . . 0.0 110.625 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 35' ' ' GLU . 12.6 p -68.86 -11.26 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.865 . . . . 0.0 109.747 179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 34' ' ' VAL . 14.8 pt-20 . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.583 179.989 . . . . . . . . 1 1 . 1 stop_ save_